H
HilleVax
HLVX
1.78000
USD
-0.07
(-3.78%)
مغلق
حجم التداول
779
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
90,110,738
العنوان: HilleVax
القطاع: Healthcare
الصناعة: Biotechnology
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.